Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Takami Miki

Showing results (1-10 of 105) with videos related to

Pageof 11
Sort By:
Clinical Calcium|January 27, 2017
[Efficacy and safety of long-term bisphosphonate treatment for osteoporosis.]Takami Miki
Clinical Calcium|January 7, 2006
[Bisphosphonate or Raloxifene?: which drug we can choose for osteoporotic patients?]Takami Miki, Shinichi Saito
Clinical Calcium|January 6, 2009
[New development in bisphosphonate treatment. Bisphosphonates and gastrointestinal adverse effects]Takami Miki, Hideki Masaki
Clinical Calcium|September 2, 2014
[Glucocorticoid and Bone. Efficacy of active vitamin D on glucocorticoid-induced osteoporosis]Takami Miki, Keiji Okamoto
Clinical Calcium|March 19, 2005
[Evaluation by metabolic markers of bone]Takami Miki, Kazuko Iba
Clinical Calcium|June 3, 2005
[Bisphosphonates and bone quality]Takami Miki, Hiroshi Naka
Clinical Calcium|March 19, 2005
[Bone mineral measurement in evaluation of osteoporosis treatment]Takami Miki, Kazuhiko Ito
Clinical Calcium|June 2, 2012
[New approved markers of bone turnover for osteoporosis in Japan]Takami Miki, Hideki Masaki
Clinical Calcium|January 7, 2006
[Strontium ranelate]Hideki Masaki, Takami Miki
Clinical Calcium|November 3, 2006
[Biochemical markers of bone in steroid (glucocorticoid)-induced osteoporosis (GIOP)]Hideki Masaki, Takami Miki
Pageof 11

Showing results (1-10 of 105) with videos related to

Sort By:
Pageof 11
Clinical Calcium|January 27, 2017
[Efficacy and safety of long-term bisphosphonate treatment for osteoporosis.]Takami Miki
Clinical Calcium|January 7, 2006
[Bisphosphonate or Raloxifene?: which drug we can choose for osteoporotic patients?]Takami Miki, Shinichi Saito
Clinical Calcium|January 6, 2009
[New development in bisphosphonate treatment. Bisphosphonates and gastrointestinal adverse effects]Takami Miki, Hideki Masaki
Clinical Calcium|September 2, 2014
[Glucocorticoid and Bone. Efficacy of active vitamin D on glucocorticoid-induced osteoporosis]Takami Miki, Keiji Okamoto
Clinical Calcium|March 19, 2005
[Evaluation by metabolic markers of bone]Takami Miki, Kazuko Iba
Clinical Calcium|June 3, 2005
[Bisphosphonates and bone quality]Takami Miki, Hiroshi Naka
Clinical Calcium|March 19, 2005
[Bone mineral measurement in evaluation of osteoporosis treatment]Takami Miki, Kazuhiko Ito
Clinical Calcium|June 2, 2012
[New approved markers of bone turnover for osteoporosis in Japan]Takami Miki, Hideki Masaki
Clinical Calcium|January 7, 2006
[Strontium ranelate]Hideki Masaki, Takami Miki
Clinical Calcium|November 3, 2006
[Biochemical markers of bone in steroid (glucocorticoid)-induced osteoporosis (GIOP)]Hideki Masaki, Takami Miki
Pageof 11